Back to Gene
RBM8A gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

RBM8A gene

The RBM8A gene provides instructions for making a protein essential for cellular functions, including messenger RNA transport and protein production.

Normal Function

The RBM8A gene provides instructions for making a protein called RNA-binding motif protein 8A. This protein is believed to be involved in several important cellular functions involving protein production. These functions include helping to transport molecules called messenger RNA (mRNA), which serve as the genetic blueprint for making proteins. RNA-binding motif protein 8A likely carries mRNA molecules from the nucleus to areas of the cell where proteins are assembled. It may also be involved in controlling how the instructions in mRNA molecules are used to build proteins and in destroying mRNA that is defective or not needed.

Health Conditions Related to Genetic Changes

Thrombocytopenia-absent radius syndrome

Mutations in the RBM8A gene cause thrombocytopenia-absent radius (TAR) syndrome. This disorder is characterized by the absence of a bone called the radius in each forearm and a shortage (deficiency) of blood cells involved in clotting (platelets).

  • Most people with TAR syndrome have a mutation in one copy of the RBM8A gene and a deletion of genetic material from chromosome 1 that includes the other copy of the RBM8A gene in each cell.
  • A small number of affected individuals have mutations in both copies of the RBM8A gene in each cell and do not have a deletion on chromosome 1.
  • RBM8A gene mutations that cause TAR syndrome reduce the amount of RNA-binding motif protein 8A in cells.
  • The deletions involved in TAR syndrome eliminate at least 200,000 DNA building blocks (200 kilobases, or 200 kb) from the long (q) arm of chromosome 1 in a region called 1q21.1.

People with either an RBM8A gene mutation and a chromosome 1 deletion or with two gene mutations have a decreased amount of RNA-binding motif protein 8A. This reduction is thought to cause problems in the development of certain tissues, but it is unknown how it causes the specific signs and symptoms of TAR syndrome. No cases have been reported in which a deletion that includes the RBM8A gene occurs on both copies of chromosome 1; studies indicate that the complete loss of RNA-binding motif protein 8A is not compatible with life.

Other Names for This Gene

  • binder of OVCA1-1
  • BOV-1
  • BOV-1A
  • BOV-1B
  • BOV-1C
  • MDS014
  • RBM8
  • RBM8A_HUMAN
  • RBM8B
  • ribonucleoprotein RBM8
  • ribonucleoprotein RBM8A
  • RNA binding motif protein 8B
  • RNA-binding motif protein 8A
  • RNA-binding protein 8A
  • RNA-binding protein Y14
  • TAR
  • Y14
  • ZNRP
  • ZRNP1

Frequently Asked Questions

Ultrasound may show absent or severely shortened radius bones and normal thumbs, along with low platelet counts detected in fetal blood sampling. If a family history of TAR exists, targeted genetic testing for RBM8A deletions/mutations can be offered.
Yes. Since TAR follows an autosomal recessive pattern, siblings have a 25 % chance of being affected if both parents are carriers. Carrier testing uses a blood or saliva sample to detect the specific RBM8A deletion or point mutation identified in the affected child, often via multiplex ligation‑dependent probe amplification (MLPA) or sequencing.
Immediate platelet count assessment is essential. If counts are <30 × 10⁹/L, platelet transfusions are given before invasive procedures. Parents are taught to avoid trauma, use soft toothbrushes, and monitor for bruising or petechiae. Hematology follow‑up is scheduled regularly to adjust transfusion needs.
Many children achieve typical height and weight with proper nutrition. Orthopedic care focuses on splinting or custom prosthetics to improve hand function, and periodic surgery may align the ulna or create a functional forearm. Early physical therapy maximizes range of motion.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA